Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis...
91 KB (6,895 words) - 01:51, 16 July 2024
Based on studies in AS, the results suggest infliximab, etanercept, and adalimumab have the potential to reduce the signs and symptoms of moderate to severely...
46 KB (4,047 words) - 21:12, 30 June 2024
superior to adalimumab for ACR50, DAS28CRP≤3.2, ΔPain and ΔHAQDI. At week 26, more participants on upadacitinib vs placebo or adalimumab achieved low...
46 KB (4,534 words) - 22:58, 20 August 2024
effects can be achieved with a monoclonal antibody such as infliximab, adalimumab, certolizumab pegol, and golimumab, or with a circulating receptor fusion...
33 KB (3,686 words) - 07:30, 20 May 2024
comprising four clinical trials which compared risankizumab to ustekinumab, adalimumab and placebo in the indication of plaque psoriasis. The results of these...
13 KB (1,018 words) - 04:46, 6 July 2024
azathioprine and antibodies, including mepolizumab, omalizumab, infliximab, and adalimumab. The word enteritis (/ˌɛntəˈraɪtɪs/) uses combining forms of entero- and...
19 KB (1,905 words) - 05:45, 25 September 2024
proceeding with this at present." Biosimilars available in Australia include adalimumab, bevacizumab, enoxaparin, epoetin lambda, etanercept, filgrastim, follitropin...
95 KB (6,480 words) - 22:51, 13 May 2024
(disease-modifying antirheumatic drugs), monoclonal antibodies, such as infliximab and adalimumab, the TNF inhibitor etanercept, and methotrexate for moderate to severe...
15 KB (1,475 words) - 18:27, 16 September 2024
TNF inhibitor in 1998. Infliximab as well as other TNF inhibitors like adalimumab, certolizumab, and golimumab are currently the most common biologics used...
28 KB (3,327 words) - 19:25, 25 July 2024